Danish hearing aid company Demant has noted a strong market upswing in the first half of 2021, having rebounded from the very low levels of the same period last year when the coronavirus pandemic stalled the market and postponed patients' visits to audiology clinics.
In the second quarter of this year, the company saw the release of pent-up demand from the US market – a ketchup effect, so to speak – being that many hearing-impaired customers delayed their adoption of hearing aids.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
Product specialist 
Pharmacovigliance (Associate) Director or Senior Specialist 
Process Supporter working with SAP 
Manager of QA, BHS Logistics 
CMC Writer 
Vice President, Medical Affairs 
Lab Manager 
Senior/lead consultant at Emendo Engineering 
Sales Manager Denmark 
eTMF Manager 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Chief Business Officer 
Senior CMC Regulatory Manager 
Scientist Radiochemistry 
Ambitious Business Relationship Manager for the Danish Medicines Agency